← Back

Evove 🇬🇧

Series A

Precision membrane technology improving filtration and separation for lithium, green hydrogen, desalination and water treatment.

About Evove

Evove specializes in precision membrane technology that enhances filtration and separation processes, utilizing its Enhance and Separonics product lines to improve flux rates and reduce energy consumption. The company integrates advanced materials, engineering, and artificial intelligence to address environmental challenges in sectors such as lithium, green hydrogen, desalination, and water treatment.

Evove is a UK-based company founded in 2015, now around 29 people. It has raised $33.9M in disclosed funding.

Founder: Tim Harper (Founder; repeat founder; previously Aero-Therm Products Ltd, Biomedical Innovation; Northumbria University).

Its investors also appear on FundFinder's most-active lists for Series A · B2B (80 funds), Series A · Generalist (64 funds), Series A · Healthcare & Wellbeing (54 funds).

Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.

Want the latest on Evove? Our research agent pulls the current description, latest round and full investor base from public sources (about a minute).

Series A · Oct 2025

  • Maven Capital Partners — Maven Capital Partners is a private equity firm that provides a range of funding options to SMEs and investment opportunities. · cheques £1M – £20M
Raising your own round? See which European funds fit →